Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) is a publicly traded Healthcare sector company. As of July 15, 2026, EPRX trades at $6.53 with a market cap of $414.17M and a P/E ratio of 0.00. EPRX moved +3.00% today. Year to date, EPRX is -16.03%; over the trailing twelve months it is +13.42%. Its 52-week range spans $2.68 to $9.32. Analyst consensus is strong buy with an average price target of $16.57. Rallies surfaces EPRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for EPRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $6.53 |
| Market Cap | $414.17M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.32 |
| 52-Week Low | $2.68 |
| Volume | 128.10K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
8 analysts cover EPRX: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.57.